Rational Design of Novel Combination Immunotherapies: Enhancing the Cytotoxic Activity of Chimeric Antigen Receptor T Cells 2019 ASPIRE Award Marco Ruella, MD (Principal); Sara Cherry, PhD; and Igor Brodsky, PhD, University of Pennsylvania Read More
Target Class Approach to Develop DUB Inhibitors 2019 ASPIRE Award; 2021 ASPIRE II Award Sara Buhrlage, PhD (Principal) and Jarrod Marto, PhD, Dana-Farber Cancer Institute Read More
Engineering TGF-β-resistant, Tri-Specific T-Cell Therapy for Glioblastoma Multiforme 2019 Emerging Leader Award Yvonne Y. Chen, PhD, University of California, Los Angeles Read More
Rational Approach to Targeting Transcription Factors with Small Molecule Degraders 2019 Emerging Leader Award Eric S. Fischer, PhD, Dana-Farber Cancer Institute Read More
Optimizing Adoptive Cell Therapy for All Patients: Towards In Vivo CAR T-Cell Manufacturing 2019 Emerging Leader Award Saar I. Gill, MD, PhD, The Abramson Cancer Center at the University of Pennsylvania Read More
Preventing Cancer Vaccine Failure via Nanoparticle-Mediated T-cell Receptor Programming 2019 Emerging Leader Award Matthias Stephan, MD, PhD, Fred Hutchinson Cancer Research Center Read More
